vs

Side-by-side financial comparison of Generation Bio Co. (GBIO) and TOP Financial Group Ltd (TOP). Click either name above to swap in a different company.

TOP Financial Group Ltd is the larger business by last-quarter revenue ($2.9M vs $1.6M, roughly 1.8× Generation Bio Co.). TOP Financial Group Ltd runs the higher net margin — 6.6% vs -346.3%, a 352.9% gap on every dollar of revenue.

Generation Bio Co. is a clinical-stage biotechnology firm focused on developing innovative non-viral gene therapies for both rare and common genetic diseases. Its core pipeline targets liver and retina disease indications, operates primarily in the U.S. market, and aims to deliver potential one-time curative treatments to patients with unmet medical needs.

Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.

GBIO vs TOP — Head-to-Head

Bigger by revenue
TOP
TOP
1.8× larger
TOP
$2.9M
$1.6M
GBIO
Higher net margin
TOP
TOP
352.9% more per $
TOP
6.6%
-346.3%
GBIO

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
GBIO
GBIO
TOP
TOP
Revenue
$1.6M
$2.9M
Net Profit
$-5.5M
$190.5K
Gross Margin
Operating Margin
-420.8%
Net Margin
-346.3%
6.6%
Revenue YoY
-78.9%
Net Profit YoY
64.0%
EPS (diluted)
$-0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GBIO
GBIO
TOP
TOP
Q3 25
$1.6M
$2.9M
Q2 25
$765.0K
Q1 25
$8.7M
Q4 24
$4.2M
Q3 24
$7.6M
Q2 24
$4.1M
Q1 24
$4.1M
Q4 23
$2.9M
Net Profit
GBIO
GBIO
TOP
TOP
Q3 25
$-5.5M
$190.5K
Q2 25
$-20.9M
Q1 25
$-14.8M
Q4 24
$-21.4M
Q3 24
$-15.3M
Q2 24
$-20.4M
Q1 24
$-74.5M
Q4 23
$-35.2M
Operating Margin
GBIO
GBIO
TOP
TOP
Q3 25
-420.8%
Q2 25
-2995.6%
Q1 25
-190.4%
Q4 24
-562.6%
Q3 24
-236.7%
Q2 24
-569.8%
Q1 24
-1912.6%
Q4 23
-1335.0%
Net Margin
GBIO
GBIO
TOP
TOP
Q3 25
-346.3%
6.6%
Q2 25
-2735.0%
Q1 25
-169.7%
Q4 24
-510.6%
Q3 24
-202.7%
Q2 24
-499.4%
Q1 24
-1836.4%
Q4 23
-1222.6%
EPS (diluted)
GBIO
GBIO
TOP
TOP
Q3 25
$-0.82
Q2 25
$-3.12
Q1 25
$-0.22
Q4 24
$4.50
Q3 24
$-2.29
Q2 24
$-3.07
Q1 24
$-1.12
Q4 23
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GBIO
GBIO
TOP
TOP
Cash + ST InvestmentsLiquidity on hand
$89.6M
$14.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$50.6M
$35.0M
Total Assets
$121.9M
$64.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GBIO
GBIO
TOP
TOP
Q3 25
$89.6M
$14.8M
Q2 25
$141.4M
Q1 25
$157.6M
Q4 24
$185.2M
Q3 24
$184.8M
Q2 24
$216.9M
Q1 24
$219.3M
Q4 23
$264.4M
Stockholders' Equity
GBIO
GBIO
TOP
TOP
Q3 25
$50.6M
$35.0M
Q2 25
$54.1M
Q1 25
$73.3M
Q4 24
$86.2M
Q3 24
$104.4M
Q2 24
$115.4M
Q1 24
$132.0M
Q4 23
$203.1M
Total Assets
GBIO
GBIO
TOP
TOP
Q3 25
$121.9M
$64.1M
Q2 25
$179.4M
Q1 25
$201.3M
Q4 24
$231.2M
Q3 24
$248.8M
Q2 24
$265.3M
Q1 24
$285.9M
Q4 23
$374.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GBIO
GBIO
TOP
TOP
Operating Cash FlowLast quarter
$-52.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GBIO
GBIO
TOP
TOP
Q3 25
$-52.7M
Q2 25
$-16.8M
Q1 25
$-28.4M
Q4 24
$-15.8M
Q3 24
$-19.5M
Q2 24
$-21.5M
Q1 24
$-31.7M
Q4 23
$-25.0M
Free Cash Flow
GBIO
GBIO
TOP
TOP
Q3 25
Q2 25
$-17.3M
Q1 25
$-28.6M
Q4 24
$-16.2M
Q3 24
$-19.6M
Q2 24
$-21.5M
Q1 24
$-33.6M
Q4 23
$-29.6M
FCF Margin
GBIO
GBIO
TOP
TOP
Q3 25
Q2 25
-2259.7%
Q1 25
-327.9%
Q4 24
-385.9%
Q3 24
-260.0%
Q2 24
-526.7%
Q1 24
-828.2%
Q4 23
-1027.0%
Capex Intensity
GBIO
GBIO
TOP
TOP
Q3 25
0.0%
Q2 25
60.0%
Q1 25
2.8%
Q4 24
9.0%
Q3 24
1.2%
Q2 24
0.3%
Q1 24
47.3%
Q4 23
159.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons